Self-administration and behavioral economics of second-generation synthetic cathinones in male rats

RationaleSynthetic cathinones have become increasingly available as drugs of abuse. Distribution of these drugs is made possible by altering the chemical structures of prohibited cathinones and marketing them under misleading labels. Very little is known about the relative reinforcing effectiveness of new synthetic cathinones relative to known drugs of abuse.ObjectiveWe examined self-administration of three second-generation synthetic cathinones: alpha-pyrrolidinopentiophenone (alpha-PVP), 4-methyl-N-ethylcathinone (4-MEC), and 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP) relative to methamphetamine.MethodMale, Sprague-Dawley rats, implanted with intravenous catheters, were trained to self-administer methamphetamine (0.05 mg/kg/injection) under a fixed-ratio schedule. Following training, various doses of methamphetamine (0.006-0.1 mg/kg/injection), alpha-PVP (0.0015-0.1 mg/kg/injection), 4-MEC (0.1-3.2 mg/kg/injection), or 4-MePPP (0.1-0.8 mg/kg/injection) were available for self-administration in separate groups, followed by a behavioral-economics evaluation of the reinforcing effectiveness of each drug.ResultsFor all drugs, at least one dose functioned as a reinforcer. Alpha-PVP and 4-MePPP maintained the highest numbers of infusions per session and both were more effective reinforcers relative to methamphetamine. 4-MEC and methamphetamine were not significantly different in terms of infusions per session or reinforcing effectiveness.ConclusionEmerging synthetic cathinones whose primary pharmacological mechanism is to block dopamine uptake but with little effects on monoamine release or serotonin uptake may have a greater degree of abuse potential compared with known abused stimulants.

[1]  J. Ramsey,et al.  High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: Neural consequences and comparison with methamphetamine , 2013, Journal of psychopharmacology.

[2]  Laurent Karila,et al.  Synthetic Cathinones: A New Public Health Problem , 2015, Current neuropharmacology.

[3]  A. G. Santos,et al.  Schedules of Controlled Substances : Placement of Methylone Into Schedule , 2016 .

[4]  D. Horton,et al.  A translational pharmacology approach to understanding the predictive value of abuse potential assessments , 2013, Behavioural pharmacology.

[5]  K. Freeman,et al.  Predicting abuse potential of stimulants and other dopaminergic drugs: Overview and recommendations , 2014, Neuropharmacology.

[6]  Benzodiazepine and neuroactive steroid combinations in rats: anxiolytic-like and discriminative stimulus effects , 2016, Psychopharmacology.

[7]  W. Woolverton,et al.  Estimating the relative reinforcing strength of (±)-3,4-methylenedioxymethamphetamine (MDMA) and its isomers in rhesus monkeys: comparison to (+)-methamphetamine , 2006, Psychopharmacology.

[8]  Belinda Weimer,et al.  National Forensic Laboratory Information System special report: Synthetic cannabinoids and synthetic cathinones reported in NFLIS, 2010-2013 , 2014 .

[9]  S. Negus,et al.  Micro/kappa opioid interactions in rhesus monkeys: implications for analgesia and abuse liability. , 2008, Experimental and clinical psychopharmacology.

[10]  Ruth A. Carter Schedules of controlled substances: temporary placement of 10 synthetic cathinones into Schedule I. Final order. , 2014, Federal register.

[11]  S R Hursh,et al.  Normalized demand for drugs and other reinforcers. , 1995, Journal of the experimental analysis of behavior.

[12]  T. Dickerson,et al.  In vivo potency and efficacy of the novel cathinone α-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats , 2015, Psychopharmacology.

[13]  B. Blough,et al.  Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3,4-methylenedioxypyrovalerone (MDPV) , 2014, Neuropharmacology.

[14]  B. Blough,et al.  Cocaine‐like discriminative stimulus effects of alpha‐pyrrolidinovalerophenone, methcathinone and their 3,4‐methylenedioxy or 4‐methyl analogs in rhesus monkeys , 2017, Addiction biology.

[15]  Kurt R. Lehner,et al.  ‘Second-Generation’ Mephedrone Analogs, 4-MEC and 4-MePPP, Differentially Affect Monoamine Transporter Function , 2015, Neuropsychopharmacology.

[16]  B. Pitt Psychopharmacology , 1968, Mental Health.

[17]  Establishment of drug codes for 26 substances. Final rule. , 2013, Federal register.

[18]  Michael H Baumann,et al.  Awash in a sea of 'bath salts': implications for biomedical research and public health. , 2014, Addiction.

[19]  M. Liechti,et al.  Monoamine transporter and receptor interaction profiles of a new series of designer cathinones , 2014, Neuropharmacology.

[20]  B. Blough,et al.  Discriminative-stimulus effects of second generation synthetic cathinones in methamphetamine-trained rats. , 2015, Drug and alcohol dependence.

[21]  C. Johanson,et al.  Preference in rhesus monkeys given a choice between cocaine and d,l-cathinone. , 1984, Journal of the experimental analysis of behavior.

[22]  T. Dickerson,et al.  The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: Self-administration and locomotor activity in rats , 2013, Neuropharmacology.

[23]  M. Olive,et al.  Potent rewarding and reinforcing effects of the synthetic cathinone 3,4‐methylenedioxypyrovalerone (MDPV) , 2014, Addiction biology.

[24]  Peter G. Roma,et al.  Corn oil, but not cocaine, is a more effective reinforcer in obese than in lean Zucker rats , 2015, Physiology & Behavior.

[25]  M. Nader,et al.  A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") with cocaine in rhesus monkeys. , 2005, Drug and alcohol dependence.

[26]  M. Olive,et al.  Effects of α‐Pyrrolidinopentiophenone and 4-Methyl-N-Ethylcathinone, Two Synthetic Cathinones Commonly Found in Second-Generation “Bath Salts,” on Intracranial Self-Stimulation Thresholds in Rats , 2014, The international journal of neuropsychopharmacology.

[27]  Steven R Hursh,et al.  Economic demand and essential value. , 2008, Psychological review.

[28]  W. Bickel,et al.  Behavioral economics of drug self-administration. I. Functional equivalence of response requirement and drug dose. , 1990, Life sciences.

[29]  L. Iversen,et al.  Designer psychostimulants: Pharmacology and differences , 2014, Neuropharmacology.

[30]  Discriminative and locomotor effects of five synthetic cathinones in rats and mice , 2014, Psychopharmacology.

[31]  M. Forster,et al.  Comparative Behavioral Pharmacology of Three Pyrrolidine-Containing Synthetic Cathinone Derivatives , 2015, The Journal of Pharmacology and Experimental Therapeutics.

[32]  Magalie Paillet-Loilier,et al.  Emerging drugs of abuse: current perspectives on substituted cathinones , 2014 .

[33]  R. Griffiths,et al.  Principles of drug abuse liability assessment in laboratory animals. , 2003, Drug and alcohol dependence.